+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fluticasone Furoate"

Lower Respiratory Tract Therapeutics Global Market Report 2024 - Product Thumbnail Image

Lower Respiratory Tract Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
Trimbow - Product Thumbnail Image

Trimbow

  • Report
  • July 2018
  • 17 Pages
  • Global
From
Trelegy Ellipta - Product Thumbnail Image

Trelegy Ellipta

  • Report
  • July 2018
  • 30 Pages
  • Global
From
Breo Ellipta - Product Thumbnail Image

Breo Ellipta

  • Report
  • July 2018
  • 41 Pages
  • Global
From
Drug Analysis: Breo Ellipta - Product Thumbnail Image

Drug Analysis: Breo Ellipta

  • Drug Pipelines
  • February 2018
  • 39 Pages
  • Global
From
Drug Analysis: Trelegy Ellipta - Product Thumbnail Image

Drug Analysis: Trelegy Ellipta

  • Drug Pipelines
  • February 2018
  • 16 Pages
  • Global
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Fluticasone Furoate is a corticosteroid used to treat respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is used to reduce inflammation in the airways, which helps to reduce symptoms such as wheezing, coughing, and shortness of breath. Fluticasone Furoate is available in both inhaler and nasal spray forms, and is often used in combination with other medications to provide the best results. Fluticasone Furoate is a widely used medication in the respiratory drug market, and is often prescribed as a first-line treatment for asthma and COPD. It is generally well-tolerated and has few side effects, making it a popular choice for many patients. Some companies that produce Fluticasone Furoate include GlaxoSmithKline, Merck, and Mylan. Other companies that produce generic versions of the drug include Teva Pharmaceuticals, Sandoz, and Sun Pharmaceuticals. Show Less Read more